To investigate whether the effect was restricted to control only arthritis development or also other autoimmune diseases, we tested experimental autoimmune encephalomyelitis (EAE), a T-cell-dependent model of MS, which confirmed the EA2 mediated protective effect seen in arthritis (Fig. 2g). The gene discussed is CACNA1A; the disease is myeloid sarcoma.